Cargando…

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice

Alzheimer’s disease (AD) is the most common type of dementia and has no effective therapies. Previous studies showed that bone morphogenetic protein 9 (BMP9), an important factor in the differentiation and phenotype maintenance of cholinergic neurons, ameliorated the cholinergic defects resulting fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zigao, Xiong, Lu, Wan, Wenbin, Duan, Lijie, Bai, Xiaojing, Zu, Hengbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296319/ https://www.ncbi.nlm.nih.gov/pubmed/28228716 http://dx.doi.org/10.3389/fnmol.2017.00032

Ejemplares similares

Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
por: Yang, Wenjuan, et al.
Publicado: (2018)

Recurrent Stroke as the Clinical Onset of POEMS Syndrome
por: Wang, Zigao, et al.
Publicado: (2017)

Toxic Leukoencephalopathy and Hypokalemia Due to Exposure to Trimethyltin
por: Wang, Zigao, et al.
Publicado: (2017)

The Cyanthin Diterpenoid and Sesterterpene Constituents of Hericium erinaceus Mycelium Ameliorate Alzheimer’s Disease-Related Pathologies in APP/PS1 Transgenic Mice
por: Tzeng, Tsai-Teng, et al.
Publicado: (2018)

20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis
por: Lin, Kaili, et al.
Publicado: (2021)

Effects of (−)Epicatechin on the Pathology of APP/PS1 Transgenic Mice
por: Zeng, Yue-Qin, et al.
Publicado: (2014)

An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice
por: Cheng, Yu‐Sung, et al.
Publicado: (2017)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022)

DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss
por: Zhou, Wei, et al.
Publicado: (2019)

Trichostatin A ameliorates Alzheimer’s disease-related pathology and cognitive deficits by increasing albumin expression and Aβ clearance in APP/PS1 mice
por: Su, Qiang, et al.
Publicado: (2021)

BMP4 overexpression induces the upregulation of APP/Tau and memory deficits in Alzheimer’s disease
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Autophagic Degradation Deficit Involved in Sevoflurane-Induced Amyloid Pathology and Spatial Learning Impairment in APP/PS1 Transgenic Mice
por: Geng, Pengcheng, et al.
Publicado: (2018)

Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer’s Disease Model Mice, APP/PS1
por: Owona, Brice Ayissi, et al.
Publicado: (2019)

Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies
por: Li, Cong, et al.
Publicado: (2017)

p38α‐MAPK‐deficient myeloid cells ameliorate symptoms and pathology of APP‐transgenic Alzheimer's disease mice
por: Luo, Qinghua, et al.
Publicado: (2022)

Partial inhibition of mitochondrial complex I ameliorates Alzheimer’s disease pathology and cognition in APP/PS1 female mice
por: Stojakovic, Andrea, et al.
Publicado: (2021)

Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model
por: Yang, Cui-cui, et al.
Publicado: (2020)

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)

LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation
por: Yin, Zequn, et al.
Publicado: (2020)

Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells
por: Yang, Yunjie, et al.
Publicado: (2020)

Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice
por: Wang, Sheng, et al.
Publicado: (2019)

Treadmill Exercise Ameliorates Adult Hippocampal Neurogenesis Possibly by Adjusting the APP Proteolytic Pathway in APP/PS1 Transgenic Mice
por: Yu, Haizhen, et al.
Publicado: (2021)

Cellular cholesterol loss by DHCR24 knockdown leads to Aβ production by changing APP intracellular localization
por: Huang, Yue, et al.
Publicado: (2023)

Nrf2 Ablation Promotes Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice: The Role of Neuroinflammation and Oxidative Stress
por: Ren, Peng, et al.
Publicado: (2020)

Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer’s disease-like pathology in APP/PS1 mice
por: Menden, Ariane, et al.
Publicado: (2022)

Ligustilide Ameliorates Memory Deficiency in APP/PS1 Transgenic Mice via Restoring Mitochondrial Dysfunction
por: Xu, Yi-Jun, et al.
Publicado: (2018)

Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
por: Li, Lei, et al.
Publicado: (2020)

(−)-Epigallocatechin-3-Gallate Ameliorates Learning and Memory Deficits by Adjusting the Balance of TrkA/p75(NTR) Signaling in APP/PS1 Transgenic Mice
por: Liu, Mingyan, et al.
Publicado: (2013)

Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction
por: Yang, Cuicui, et al.
Publicado: (2020)

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
por: Hiltunen, Mikko, et al.
Publicado: (2012)

Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
por: Zhang, Xueju, et al.
Publicado: (2020)

Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012)

Chronic Intranasal Treatment with an Anti-Aβ(30-42) scFv Antibody Ameliorates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Cattepoel, Susann, et al.
Publicado: (2011)

Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer’s Disease-Like Pathology in APP/PS1 Transgenic Mice
por: Zhao, Yongjia, et al.
Publicado: (2018)

Osthole/borneol thermosensitive gel via intranasal administration enhances intracerebral bioavailability to improve cognitive impairment in APP/PS1 transgenic mice
por: Wu, Fanchang, et al.
Publicado: (2023)

Ferulic Acid Ameliorates Alzheimer’s Disease-like Pathology and Repairs Cognitive Decline by Preventing Capillary Hypofunction in APP/PS1 Mice
por: Wang, Ni-Ya, et al.
Publicado: (2021)

(-)-Epigallocatechin-3-gallate ameliorates learning and memory impairments by attenuating peroxidation in APP/PS1 transgenic mice
por: Liu, Mingyan, et al.
Publicado: (2012)

Bis(9)-(−)-Meptazinol, a novel dual-binding AChE inhibitor, rescues cognitive deficits and pathological changes in APP/PS1 transgenic mice
por: Shi, Yuhuan, et al.
Publicado: (2018)

Humulus japonicus inhibits the progression of Alzheimer's disease in a APP/PS1 transgenic mouse model
por: Park, Tae-Shin, et al.
Publicado: (2017)

Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice
por: Sun, Jing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n8kubj0p98ohqpm9t9dl2bqhh1